Mena FN

Dengue Fever Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, And Pipeline Analysis Johnson & Johnson, Novartis Pharmaceuticals, Merck Sharp & Dohme ...

"Dengue Fever Clinical Trials"DelveInsight's,“Dengue Fever - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Dengue Fever pipeline landscape ...
Business Wire

U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus

WALTHAM, Mass.--(BUSINESS WIRE)--EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the ...
European Medical Journal

Dengue And Aging Create New Care Challenges

Dengue and aging are reshaping clinical risk, with older adults facing more severe disease, diagnostic uncertainty, and ...
Nature

Cardiovascular manifestations of the emerging dengue pandemic

The majority of dengue virus infections are mild; only a small proportion of patients develop overt complications, which can include systemic vascular leak syndrome, bleeding, and organ impairment ...